Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.085 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |